REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $10,065,000 | -84.5% | 71,115 | -86.5% | 5.43% | -64.9% |
| Q4 2020 | $64,901,000 | +122.1% | 525,000 | +75.0% | 15.45% | +4.2% |
| Q3 2020 | $29,226,000 | +27.0% | 300,000 | +103.4% | 14.82% | -0.6% |
| Q2 2020 | $23,013,000 | -16.1% | 147,500 | -22.4% | 14.91% | -49.6% |
| Q1 2020 | $27,425,000 | -30.1% | 190,000 | -1.0% | 29.60% | +40.4% |
| Q4 2019 | $39,251,000 | – | 192,000 | – | 21.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 3,063,567 | $298,453,000 | 49.63% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 150,000 | $14,613,000 | 19.62% |
| Corriente Advisors, LLC | 300,000 | $29,226,000 | 14.82% |
| Prosight Management, LP | 114,554 | $11,160,000 | 5.31% |
| MADDEN SECURITIES Corp | 43,927 | $4,279,000 | 3.18% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $2,958,000 | 2.24% |
| Biondo Investment Advisors, LLC | 99,652 | $9,708,000 | 2.10% |
| Cormorant Asset Management, LP | 450,000 | $43,839,000 | 1.69% |
| Duquesne Family Office | 543,901 | $52,987,000 | 1.54% |
| AWH Capital, L.P. | 9,500 | $925,000 | 1.30% |